Skip to main content
. 2022 Sep 13;8(5):e164. doi: 10.1192/bjo.2022.563

Table 2.

Hazard ratios by outcome and antidepressant class at 5-year follow-up

Age and gender adjusted Fully adjusted
Antidepressant class Participants Observations Events Person-years Hazard ratio 95% CI Hazard ratio 95% CI
Diabetes 114 076 124 239 961 545 735
No antidepressant 872 495 551 1.00
Any antidepressant 89 50 185 1.28 (1.03–1.59) 0.83 (0.66–1.04)
SSRIs 62 46 557 0.91 (0.72–1.14) 0.64 (0.49–0.83)
Other antidepressant 38 11 503 2.03 (1.47–2.81) 1.13 (0.81–1.57)
Hypertension 107 316 117 025 2621 508 852
No antidepressant 2411 460 887 1.00 1.00
Any antidepressant 210 47 965 1.02 (0.89–1.18) 0.93 (0.81–1.08)
SSRIs 161 38 986 1.02 (0.89–1.18) 0.91 (0.77–1.07)
Other antidepressant 49 8991 1.15 (0.87–1.53) 1.02 (0.77–1.36)
CV 121 190 132 313 337 581 598
No antidepressant 306 526 413 1.00 1.00
Any antidepressant 31 55 186 1.17 (0.81–1.70) 1.04 (0.72–1.52)
SSRIs 25 43 784 1.24 (0.86–1.79) 1.12 (0.74–1.69)
Other antidepressant 7 10 619 1.18 (0.56–2.49) 1.15 (0.54–2.43)
CHD 80 964 87 972 545 388 540
No antidepressant 492 353 972 1.00 1.00
Any antidepressant 53 34 568 1.63 (1.22–2.17) 1.47 (1.10–1.95)
SSRIs 41 28 448 1.55 (1.15–2.08) 1.44 (1.04–1.99)
Other antidepressant 13 6177 1.78 (1.03–3.09) 1.59 (0.91–2.77)
CVD mortality 113 800 124 084 150 546 926
No antidepressant 135 495 849 1.00 1.00
Any antidepressant 15 51 077 1.53 (0.89–2.61) 1.21 (0.70–2.10)
SSRIs 11 41 490 1.24 (0.68–2.25) 1.16 (0.62–2.18)
Other antidepressant 4 10 220 1.50 (0.56–4.05) 1.14 (0.42–3.11)
All-cause mortality 101 609 110 788 746 488 286
No antidepressant 649 442 834 1.00 1.00
Any antidepressant 97 45 452 1.79 (1.45–2.23) 1.37 (1.10–1.70)
SSRIs 76 36 649 1.44 (1.14–1.83) 1.41 (1.11–1.80)
Other antidepressant 27 9686 1.89 (1.29–2.78) 1.30 (0.88–1.92)

SSRI, selective serotonin reuptake inhibitor; CV, cerebrovascular disease; CHD, coronary heart disease; CVD, cardiovascular disease.